Rae J - Search Results

1

Consensus statement: Expedition Inspiration 2004 Breast Cancer Symposium 'Breast Cancer--The Development and Validation of New Therapeutics'.

Lippman ME, Benz C, Chinnaiyan A, Flockhart D, Harris A, Hudis C, Osborne CK, Press MF, Rae J, Sledge GW, Van't Veer L, Wicha M. Lippman ME, et al. Among authors: rae j. Breast Cancer Res Treat. 2005 Mar;90(1):1-3. doi: 10.1007/s10549-004-1288-x. Breast Cancer Res Treat. 2005. PMID: 15770520 Free article. No abstract available.

2

Rifampin is a selective, pleiotropic inducer of drug metabolism genes in human hepatocytes: studies with cDNA and oligonucleotide expression arrays.

Rae JM, Johnson MD, Lippman ME, Flockhart DA. Rae JM, et al. J Pharmacol Exp Ther. 2001 Dec;299(3):849-57. J Pharmacol Exp Ther. 2001. PMID: 11714868

3

Triethylenethiophosphoramide is a specific inhibitor of cytochrome P450 2B6: implications for cyclophosphamide metabolism.

Rae JM, Soukhova NV, Flockhart DA, Desta Z. Rae JM, et al. Drug Metab Dispos. 2002 May;30(5):525-30. doi: 10.1124/dmd.30.5.525. Drug Metab Dispos. 2002. PMID: 11950782

4

Cytochrome P450 3A pharmacogenetics: the road that needs traveled.

Flockhart DA, Rae JM. Flockhart DA, et al. Among authors: rae jm. Pharmacogenomics J. 2003;3(1):3-5. doi: 10.1038/sj.tpj.6500144. Pharmacogenomics J. 2003. PMID: 12629575 No abstract available.

5

Genotyping for polymorphic drug metabolizing enzymes from paraffin-embedded and immunohistochemically stained tumor samples.

Rae JM, Cordero KE, Scheys JO, Lippman ME, Flockhart DA, Johnson MD. Rae JM, et al. Pharmacogenetics. 2003 Aug;13(8):501-7. doi: 10.1097/00008571-200308000-00008. Pharmacogenetics. 2003. PMID: 12893988

6

Evaluation of novel epidermal growth factor receptor tyrosine kinase inhibitors.

Rae JM, Lippman ME. Rae JM, et al. Breast Cancer Res Treat. 2004 Jan;83(2):99-107. doi: 10.1023/B:BREA.0000010702.10130.29. Breast Cancer Res Treat. 2004. PMID: 14997040 Free article.

7

Pharmacological characterization of 4-hydroxy-N-desmethyl tamoxifen, a novel active metabolite of tamoxifen.

Johnson MD, Zuo H, Lee KH, Trebley JP, Rae JM, Weatherman RV, Desta Z, Flockhart DA, Skaar TC. Johnson MD, et al. Breast Cancer Res Treat. 2004 May;85(2):151-9. doi: 10.1023/B:BREA.0000025406.31193.e8. Breast Cancer Res Treat. 2004. PMID: 15111773 Free article.

8

EGFR and EGFRvIII expression in primary breast cancer and cell lines.

Rae JM, Scheys JO, Clark KM, Chadwick RB, Kiefer MC, Lippman ME. Rae JM, et al. Breast Cancer Res Treat. 2004 Sep;87(1):87-95. doi: 10.1023/B:BREA.0000041585.26734.f9. Breast Cancer Res Treat. 2004. PMID: 15377854 Free article.

9

(-)-Gossypol enhances response to radiation therapy and results in tumor regression of human prostate cancer.

Xu L, Yang D, Wang S, Tang W, Liu M, Davis M, Chen J, Rae JM, Lawrence T, Lippman ME. Xu L, et al. Among authors: rae jm. Mol Cancer Ther. 2005 Feb;4(2):197-205. Mol Cancer Ther. 2005. PMID: 15713891

10

GREB 1 is a critical regulator of hormone dependent breast cancer growth.

Rae JM, Johnson MD, Scheys JO, Cordero KE, Larios JM, Lippman ME. Rae JM, et al. Breast Cancer Res Treat. 2005 Jul;92(2):141-9. doi: 10.1007/s10549-005-1483-4. Breast Cancer Res Treat. 2005. PMID: 15986123 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

533 results

Search Page

Filters